Chemcrux Enterprises [CHEMCRUX] vs Neogen Chemicals [NEOGEN] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Chemcrux Enterprises Ltd. wins in 14 metrics, Neogen Chemicals Ltd. wins in 6 metrics, with 0 ties. Chemcrux Enterprises Ltd. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Chemcrux Enterprises Ltd. | Neogen Chemicals Ltd. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 64.44 | 222.22 | Chemcrux Enterprises Ltd. |
| Price-to-Book Ratio | 1.84 | 5.46 | Chemcrux Enterprises Ltd. |
| Debt-to-Equity Ratio | 50.03 | 141.47 | Chemcrux Enterprises Ltd. |
| PEG Ratio | 3.37 | -3.52 | Chemcrux Enterprises Ltd. |
| EV/EBITDA | 16.58 | 42.55 | Chemcrux Enterprises Ltd. |
| Profit Margin (TTM) | 2.87% | 2.41% | Chemcrux Enterprises Ltd. |
| Operating Margin (TTM) | 10.60% | 11.39% | Neogen Chemicals Ltd. |
| EBITDA Margin (TTM) | 10.60% | 11.39% | Neogen Chemicals Ltd. |
| Return on Equity | 5.24% | 4.41% | Chemcrux Enterprises Ltd. |
| Return on Assets (TTM) | 3.08% | 1.99% | Chemcrux Enterprises Ltd. |
| Free Cash Flow (TTM) | $-8.03M | $-1.22B | Chemcrux Enterprises Ltd. |
| Dividend Yield | 0.74% | 0.19% | Chemcrux Enterprises Ltd. |
| 1-Year Return | -34.43% | 22.53% | Neogen Chemicals Ltd. |
| Price-to-Sales Ratio (TTM) | 1.84 | 5.56 | Chemcrux Enterprises Ltd. |
| Enterprise Value | $1.52B | $53.55B | Neogen Chemicals Ltd. |
| EV/Revenue Ratio | 2.09 | 6.55 | Chemcrux Enterprises Ltd. |
| Gross Profit Margin (TTM) | 65.93% | 47.11% | Chemcrux Enterprises Ltd. |
| Revenue per Share (TTM) | $49 | $310 | Neogen Chemicals Ltd. |
| Earnings per Share (Diluted) | $1.40 | $7.47 | Neogen Chemicals Ltd. |
| Beta (Stock Volatility) | 0.08 | 0.22 | Chemcrux Enterprises Ltd. |
Chemcrux Enterprises Ltd. vs Neogen Chemicals Ltd. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Chemcrux Enterprises Ltd. | 0.36% | 0.92% | -1.68% | 13.31% | -17.85% | -16.20% |
| Neogen Chemicals Ltd. | 1.51% | 8.10% | 24.00% | 48.67% | 91.41% | 75.54% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Chemcrux Enterprises Ltd. | -34.43% | -72.45% | -68.11% | 147.96% | 147.96% | 147.96% |
| Neogen Chemicals Ltd. | 22.53% | 26.54% | 147.06% | 676.07% | 676.07% | 676.07% |
Performance & Financial Health Analysis: Chemcrux Enterprises Ltd. vs Neogen Chemicals Ltd.
| Metric | CHEMCRUX | NEOGEN |
|---|---|---|
| Market Information | ||
| Market Cap | ₹1.34B | ₹44.76B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 13,175 | 170,744 |
| 90 Day Avg. Volume | 13,754 | 127,390 |
| Last Close | ₹90.08 | ₹2,064.40 |
| 52 Week Range | ₹64.00 - ₹158.60 | ₹966.70 - ₹2,087.30 |
| % from 52W High | -43.20% | -1.10% |
| All-Time High | ₹501.10 (Aug 29, 2022) | ₹2,420.00 (Dec 09, 2024) |
| % from All-Time High | -82.02% | -14.69% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.14% | 0.09% |
| Quarterly Earnings Growth | 0.19% | -0.63% |
| Financial Health | ||
| Profit Margin (TTM) | 0.03% | 0.02% |
| Operating Margin (TTM) | 0.11% | 0.11% |
| Return on Equity (TTM) | 0.05% | 0.04% |
| Debt to Equity (MRQ) | 50.03 | 141.47 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹49.16 | ₹303.78 |
| Cash per Share (MRQ) | ₹13.11 | ₹57.58 |
| Operating Cash Flow (TTM) | ₹96.58M | ₹645.50M |
| Levered Free Cash Flow (TTM) | ₹39.13M | ₹348.30M |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.74% | 0.19% |
| Last 12-Month Dividend | ₹1.00 | ₹3.00 |
Valuation & Enterprise Metrics Analysis: Chemcrux Enterprises Ltd. vs Neogen Chemicals Ltd.
| Metric | CHEMCRUX (Apr 26, 2026) | NEOGEN (Apr 24, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 64.44 | 222.22 |
| Forward P/E | N/A | 72.26 |
| PEG Ratio | 3.37 | -3.52 |
| Price to Sales (TTM) | 1.84 | 5.56 |
| Price to Book (MRQ) | 1.84 | 5.46 |
| Market Capitalization | ||
| Market Capitalization | ₹1.34B | ₹44.76B |
| Enterprise Value | ₹1.52B | ₹53.55B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.09 | 6.55 |
| Enterprise to EBITDA | 16.58 | 42.55 |
| Risk & Other Metrics | ||
| Beta | 0.08 | 0.22 |
| Book Value per Share (MRQ) | ₹49.16 | ₹303.78 |
Financial Statements Comparison: Chemcrux Enterprises Ltd. vs Neogen Chemicals Ltd.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | CHEMCRUX (2025) | NEOGEN (2025) |
|---|---|---|
| Revenue/Sales | 576.25M | 7.58B |
| Cost of Goods Sold | 459.08M | 4.44B |
| COGS % of Revenue | 79.7% | 58.6% |
| Gross Profit | 117.17M | 3.13B |
| Gross Margin | 20.3% | 41.4% |
| Research & Development | N/A | 11.50M |
| Operating Income (EBIT) | 60.29M | 1.09B |
| Operating Margin | 10.5% | 14.4% |
| EBITDA | 104.11M | 1.31B |
| EBITDA Margin | 18.1% | 17.3% |
| Pre-Tax Income | 57.60M | 501.60M |
| Pre-Tax Income % of Revenue | 10.0% | 6.6% |
| Income Tax | 18.47M | 153.30M |
| Income Tax % of Revenue | 3.2% | 2.0% |
| Net Income (Profit) | 39.13M | 348.30M |
| Profit Margin | 6.8% | 4.6% |
Balance Sheet & Liquidity Metrics
| Metric | CHEMCRUX (2025) | NEOGEN (2025) |
|---|---|---|
| Cash & Equivalents | 10.16M | 49.60M |
| Total Current Assets | 463.25M | 10.00B |
| Total Current Assets % of Revenue | 80.4% | 132.0% |
| Total Current Liabilities | 200.42M | 7.33B |
| Total Current Liabilities % of Revenue | 34.8% | 96.8% |
| Long-Term Debt | 286.55M | 1.94B |
| Long-Term Debt % of Revenue | 49.7% | 25.6% |
| Total Shareholders Equity | 746.23M | 7.89B |
| Retained Earnings | 579.19M | 2.28B |
| Retained Earnings % of Revenue | 100.5% | 30.1% |
| Property, Plant & Equipment | 21.28M | 890.30M |
Cash Flow Statement Comparison
| Metric | CHEMCRUX (2025) | NEOGEN (2025) |
|---|---|---|
| Operating Cash Flow | 96.58M | 645.50M |
| Operating Cash Flow % of Revenue | 16.8% | 8.5% |
| Capital Expenditures | -82.26M | -3.17B |
| Free Cash Flow | -8.03M | -1.22B |
| FCF Margin | -1.4% | -16.1% |
| Debt Repayment | N/A | -718.00M |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | CHEMCRUX | NEOGEN |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Shares Outstanding | 14.81M | 27.38M |
| Float Shares | 3.58M | 13.28M |
| % Held by Insiders | 75.89% | 53.98% |
| % Held by Institutions | 0.00% | 23.81% |
| % Held by Public | 24.11% | 22.21% |
Dividend Analysis & Yield Comparison: Chemcrux Enterprises Ltd. vs Neogen Chemicals Ltd.
| Metric | CHEMCRUX | NEOGEN |
|---|---|---|
| Last 12-Month Dividend | ₹1.00 | ₹3.00 |
| Last 12-Month Dividend Yield | 0.74% | 0.19% |
| 3-Year Avg Annual Dividend | ₹1.67 | ₹2.00 |
| 3-Year Avg Dividend Yield | 0.50% | 0.11% |
| 3-Year Total Dividends | ₹5.00 | ₹6.00 |
| Ex-Dividend Date | Sep 06, 2024 | Sep 19, 2025 |